Role of Digestive Enzymes in Symptom Management of Irritable Bowel Syndrome and Lactose Intolerance: A Cross-Sectional Study
Journal of Health, Wellness and Community Research · 02.06.2026 · 4 (11) · 1-11
DOI: 10.61919/6pxk6f30 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Journal of Health, Wellness and Community Research, online erschienen am 02.06.2026. Verfasst von Faisal Khan und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Irritable bowel syndrome and lactose intolerance commonly present with overlapping gastrointestinal symptoms, including bloating, abdominal pain, flatulence, diarrhea, constipation, and post-meal discomfort. In settings where dairy products, milk tea, pulses, beans, and heavy mixed meals are frequently consumed, digestive enzyme supplementation may offer symptom-specific supportive benefit.
Objective
To assess the association between digestive enzyme use and patient-reported symptom relief among adults with IBS-like and lactose intolerance-related gastrointestinal symptoms in Quetta, Pakistan.
Methods
This cross-sectional observational study included 250 adults aged 18–60 years presenting with symptoms suggestive of IBS, lactose intolerance, or overlapping features. Data were collected using a structured questionnaire covering demographic characteristics, symptom patterns, dietary triggers, digestive enzyme use, and perceived symptom relief. Digestive enzyme users and non-users were described, and symptom-specific improvement among enzyme users was analyzed using frequencies, percentages, confidence intervals, and p-values.
Results
Of 250 participants, 138 were female and 112 were male, with a mean age of 34.8 ± 10.6 years. IBS-only symptoms were reported by 96 participants, lactose intolerance-only symptoms by 58, and overlapping symptoms by 96. Digestive enzyme use was reported by 142 participants. Improvement was highest for bloating (79.6%), flatulence/gas (73.9%), and diarrhea after dairy intake (68.4%), followed by post-meal heaviness (64.1%) and abdominal pain (60.6%). Constipation showed the weakest improvement (37.3%).
Conclusion
Digestive enzyme supplementation was associated with greater patient-reported relief of gas-related and dairy-associated symptoms than constipation-predominant complaints, supporting phenotype-directed use as an adjunctive symptom-management strategy.
Zitieren
APA
Khan, F., Bari, N., Khan, M., Siddique, M., Khan, M. I., Muhammad, P. S. K., & Hammad, M. (2026). Role of Digestive Enzymes in Symptom Management of Irritable Bowel Syndrome and Lactose Intolerance: A Cross-Sectional Study. Journal of Health, Wellness and Community Research, 4(11), 1-11. https://doi.org/10.61919/6pxk6f30
Vancouver
Khan F, Bari N, Khan M, Siddique M, Khan MI, Muhammad PSK, et al. Role of Digestive Enzymes in Symptom Management of Irritable Bowel Syndrome and Lactose Intolerance: A Cross-Sectional Study. Journal of Health, Wellness and Community Research. 2026;4(11):1-11. doi:10.61919/6pxk6f30
BibTeX
@article{Khan2026,
author = {Khan, Faisal and Bari, Naila and Khan, Masood and Siddique, Memoona and Khan, Muhammad Iftikhar and Muhammad, Prof. Shaikh Khalid and Hammad, Muhammad},
title = {Role of Digestive Enzymes in Symptom Management of Irritable Bowel Syndrome and Lactose Intolerance: A Cross-Sectional Study},
journal = {Journal of Health, Wellness and Community Research},
year = {2026},
volume = {4},
number = {11},
pages = {1--11},
doi = {10.61919/6pxk6f30}
}
EUVIMED